Jazz Pharmaceuticals Officer Renee Gala Files Form 144 for $472K Share Sale

Executive Summary

On October 6, 2026, Renee D. Gala, an Officer of Jazz Pharmaceuticals plc ($JAZZ), submitted a Form 144 notice indicating an intention to sell 2,000 ordinary shares with an aggregate market value of approximately $472,800 (implied price of $236.40 per share).

Transaction Details

• Security: Common Shares
• Number of Shares: 2,000
• Estimated Aggregate Market Value: $472,800.00
• Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
• Acquisition Origin: Restricted stock granted by the issuer on June 30, 2026.
• Rule 10b5-1 Plan: The proposed sale is executed pursuant to a trading plan adopted on June 4, 2026.
• Prior Sales: In the preceding three months, the reporting person sold 2,000 shares on September 8, 2026, generating gross proceeds of $486,060.00.

Market & Governance Impact

The proposed transaction represents approximately 0.003% of Jazz Pharmaceuticals' 64,914,577 total outstanding shares. Because this transaction is of modest size relative to the company's total float and is governed by a pre-established Rule 10b5-1 trading arrangement, its market significance is assessed as Low.